1. Home
  2. VTSI vs JSPR Comparison

VTSI vs JSPR Comparison

Compare VTSI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.65

Market Cap

51.1M

ML Signal

HOLD

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$1.02

Market Cap

23.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
JSPR
Founded
1993
2018
Country
United States
United States
Employees
N/A
22
Industry
Miscellaneous manufacturing industries
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.1M
23.1M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
VTSI
JSPR
Price
$4.65
$1.02
Analyst Decision
Strong Buy
Buy
Analyst Count
1
11
Target Price
$5.00
$15.50
AVG Volume (30 Days)
80.4K
579.3K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$185,971.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$27.30
N/A
P/E Ratio
$235.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$0.62
52 Week High
$7.47
$7.19

Technical Indicators

Market Signals
Indicator
VTSI
JSPR
Relative Strength Index (RSI) 63.15 50.87
Support Level $4.63 $0.62
Resistance Level $5.15 $1.44
Average True Range (ATR) 0.26 0.11
MACD 0.11 0.03
Stochastic Oscillator 79.72 76.05

Price Performance

Historical Comparison
VTSI
JSPR

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: